TSPYL5 and non-small cell lung carcinoma: Treatment of NSCLC A549 cells with the PEGylated TSPYL5-derived peptides, particularly TS120-T and TS120-D, resulted in significantly reduced self-renewal and metastatic capacities, as shown by sphere-forming assay and invasion/migration assays (Fig. 8c).